Alyeska Investment Group’s QuidelOrtho QDEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,000
Closed -$3.65M 635
2023
Q3
$3.65M Sell
50,000
-954,988
-95% -$76.3M 0.02% 358
2023
Q2
$83.3M Sell
1,004,988
-142,475
-12% -$12.5M 0.62% 40
2023
Q1
$102M Buy
1,147,463
+70,499
+7% +$6.13M 0.89% 20
2022
Q4
$92.3M Buy
+1,076,964
New +$91.2M 0.95% 11
2022
Q1
Sell
-52,750
Closed -$7.12M 656
2021
Q4
$7.12M Sell
52,750
-22,250
-30% -$3.1M 0.08% 231
2021
Q3
$10.6M Buy
+75,000
New +$10.1M 0.13% 192
2020
Q4
Sell
-25,000
Closed -$5.49M 586
2020
Q3
$5.49M Buy
+25,000
New +$5.58M 0.08% 251
2014
Q1
Sell
-100,000
Closed -$3.09M 383
2013
Q4
$3.09M Buy
+100,000
New +$2.57M 0.12% 203

Other funds holding QDEL

Alyeska Investment Group's QDEL Position: Q4 2023 in Review

Alyeska Investment Group sold out of QuidelOrtho (QDEL) in Q4 2023, closing a stake of 50,000 shares — an estimated $3.65M sold.

Alyeska Investment Group first reported a position in QDEL in Q4 2013 and held it in 8 quarters. The position peaked at $102M in Q1 2023. 306 funds tracked by Wall St. Rank hold QDEL as of Q4 2023.

  • Alyeska Investment Group reported no remaining QuidelOrtho position as of Q4 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 50,000 QuidelOrtho shares in Q4 2023, an estimated $3.65M.
  • Alyeska Investment Group first reported a position in QuidelOrtho in Q4 2013 and held it in 8 quarters.
  • Alyeska Investment Group's QuidelOrtho position peaked at $102M in Q1 2023.
  • 306 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2023.

Based on Alyeska Investment Group's 13F filing for Q4 2023, filed 14 Feb 2024.